STOCKWATCH
·
Pharmaceuticals
Acquisitions24 Mar 2026, 02:26 pm

Rekvina Laboratories Receives Open Offer from Vivro Financial Services

AI Summary

Vivro Financial Services Pvt Ltd, the manager to the open offer, has submitted a detailed public statement for the attention of the equity shareholders of Rekvina Laboratories. The statement, published in compliance with Regulation 13(4) and 14(3) of the SEBI SAST Regulations, was published in the Financial Express (English), Jansatta (Hindi), and Navshakti (Marathi) on March 24, 2026. The open offer is in relation to the acquisition of Rekvina Laboratories.

Key Highlights

  • Vivro Financial Services Pvt Ltd is the manager to the open offer for Rekvina Laboratories
  • The detailed public statement was published in the Financial Express (English), Jansatta (Hindi), and Navshakti (Marathi)
  • The open offer is in compliance with Regulation 13(4) and 14(3) of the SEBI SAST Regulations
  • The open offer is for the acquisition of Rekvina Laboratories
  • The statement includes the highest negotiated price per share, volume-weighted average price, and volume-weighted average market price
VINRKLB
Pharmaceuticals
Rekvina Laboratories Ltd

Price Impact